Cargando…

Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China

Objective: To investigate the drug resistance characteristics of Mycobacterium tuberculosis (MTB) isolates from patients with tuberculosis to 12 antituberculous drugs in China. Methods: All clinical isolates of MTB were isolated from patients with tuberculosis in Shanghai Pulmonary Hospital (SPH) du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiaocui, Yang, Jinghui, Tan, Guangkun, Liu, Haican, Liu, Yin, Guo, Yinjuan, Gao, Rongliang, Wan, Baoshan, Yu, Fangyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849330/ https://www.ncbi.nlm.nih.gov/pubmed/31828045 http://dx.doi.org/10.3389/fcimb.2019.00345

Ejemplares similares

Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures
por: Wu, Xiaocui, et al.
Publicado: (2022)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

Transcriptional regulation and drug resistance in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2022)

The evolving biology of Mycobacterium tuberculosis drug resistance
por: Jones, Richard M., et al.
Publicado: (2022)

A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB(®) Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples
por: Bonnet, Isabelle, et al.
Publicado: (2021)

Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance
por: Samuels, Amanda N., et al.
Publicado: (2022)

Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis
por: Poulton, Nicholas C., et al.
Publicado: (2022)

Evolution of Mycobacterium tuberculosis drug resistance in the genomic era
por: Nimmo, Camus, et al.
Publicado: (2022)

Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
por: Stanley, Sydney, et al.
Publicado: (2022)

Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis
por: Eoh, Hyungjin, et al.
Publicado: (2022)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
por: Bhagwat, Amala, et al.
Publicado: (2022)

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
por: Greenstein, Talia, et al.
Publicado: (2023)

Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host
por: Schami, Alyssa, et al.
Publicado: (2023)

Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular Mycobacterium tuberculosis
por: Rienksma, Rienk A., et al.
Publicado: (2019)

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2022)

Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design
por: Rudraraju, Reshma S., et al.
Publicado: (2022)

Transcriptional Profile of Mycobacterium tuberculosis in an in vitro Model of Intraocular Tuberculosis
por: Abhishek, Sudhanshu, et al.
Publicado: (2018)

Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
por: Verma, Akanksha, et al.
Publicado: (2022)

The role of Mycobacterium tuberculosis acetyltransferase and protein acetylation modifications in tuberculosis
por: Huang, Yinxia, et al.
Publicado: (2023)

Whole Genome and Transcriptome Sequencing of Two Multi-Drug Resistant Mycobacterium tuberculosis Strains to Facilitate Illustrating Their Virulence in vivo
por: Tang, Jun, et al.
Publicado: (2020)

Triacylglycerols: Fuelling the Hibernating Mycobacterium tuberculosis
por: Maurya, Rahul Kumar, et al.
Publicado: (2019)

Editorial: New insights in Mycobacterium tuberculosis
por: Natarajaseenivasan, Kalimuthusamy
Publicado: (2022)

Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in Mycobacterium tuberculosis
por: Choudhary, Eira, et al.
Publicado: (2019)

The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy
por: Maphasa, Retsepile E., et al.
Publicado: (2021)

Mycobacterium tuberculosis Induced Osteoblast Dysregulation Involved in Bone Destruction in Spinal Tuberculosis
por: Ma, Wenxin, et al.
Publicado: (2022)

The Iron Response of Mycobacterium tuberculosis and Its Implications for Tuberculosis Pathogenesis and Novel Therapeutics
por: Rodriguez, G. Marcela, et al.
Publicado: (2022)

A Two-Way Proteome Microarray Strategy to Identify Novel Mycobacterium tuberculosis-Human Interactors
por: Cao, Tingming, et al.
Publicado: (2019)

Mycobacterium tuberculosis-macrophage interaction: Molecular updates
por: Bo, Haotian, et al.
Publicado: (2023)

Dimethyl fumarate eliminates differentially culturable Mycobacterium tuberculosis in an intranasal murine model of tuberculosis
por: Glenn, Sarah M., et al.
Publicado: (2022)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
por: Singh, Vinayak
Publicado: (2021)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Trends and challenges of multi-drug resistance in childhood tuberculosis
por: Zhuang, Zengfang, et al.
Publicado: (2023)

Machine Learning Algorithms Evaluate Immune Response to Novel Mycobacterium tuberculosis Antigens for Diagnosis of Tuberculosis
por: Meier, Noëmi Rebecca, et al.
Publicado: (2021)

Modeling the Metabolic State of Mycobacterium tuberculosis Upon Infection
por: Rienksma, Rienk A., et al.
Publicado: (2018)

Editorial: Cellular and Molecular Mechanisms of Mycobacterium tuberculosis Virulence
por: Sun, Jianjun, et al.
Publicado: (2019)

A CRISPR-Cas12a-based platform for ultrasensitive rapid highly specific detection of Mycobacterium tuberculosis in clinical application
por: Jia, Nan, et al.
Publicado: (2023)

Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children
por: Zhu, Hanzhao, et al.
Publicado: (2023)

Culture filtrate supplementation can be used to improve Mycobacterium tuberculosis culture positivity for spinal tuberculosis diagnosis
por: Beltran, Caroline G. G., et al.
Publicado: (2022)

Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management
por: Liebenberg, Dale, et al.
Publicado: (2022)

Management of Severe Gastrointestinal Tuberculosis with Injectable Antituberculous Drugs
por: Goldani, Luciano Z., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_96hdt4essipnm8olm9ij4e42f4